-
1
-
-
4143150688
-
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
-
DOI 10.1158/1078-0432.CCR-04-0220
-
T.O. Nielsen, F.D. Hsu, K. Jensen, M. Cheang, G. Karaca, and Z. Hu et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 2004 5367 5374 (Pubitemid 39100473)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.16
, pp. 5367-5374
-
-
Nielsen, T.O.1
Hsu, F.D.2
Jensen, K.3
Cheang, M.4
Karaca, G.5
Hu, Z.6
Hernandez-Boussard, T.7
Livasy, C.8
Cowan, D.9
Dressler, L.10
Akslen, L.A.11
Ragaz, J.12
Gown, A.M.13
Gilks, C.B.14
Van De Rijn, M.15
Perou, C.M.16
-
2
-
-
40949121882
-
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype
-
DOI 10.1158/1078-0432.CCR-07-1658
-
M.C.U. Cheang, D. Voduc, C. Bajdik, S. Leung, S. McKinney, and S.K. Chia et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 2008 1368 1376 (Pubitemid 351413917)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.5
, pp. 1368-1376
-
-
Cheang, M.C.U.1
Voduc, D.2
Bajdik, C.3
Leung, S.4
McKinney, S.5
Chia, S.K.6
Perou, C.M.7
Nielsen, T.O.8
-
3
-
-
83455236666
-
Basal breast cancer: A complex and deadly molecular subtype
-
F. Bertucci, P. Finetti, and D. Birnbaum Basal breast cancer: a complex and deadly molecular subtype Curr Mol Med 12 2012 96 110
-
(2012)
Curr Mol Med
, vol.12
, pp. 96-110
-
-
Bertucci, F.1
Finetti, P.2
Birnbaum, D.3
-
4
-
-
70849122251
-
Triple-negative breast cancer-current status and future directions
-
O. Gluz, C. Liedtke, N. Gottschalk, L. Pusztai, U. Nitz, and N. Harbeck Triple-negative breast cancer-current status and future directions Ann Oncol 20 2009 1913 1927
-
(2009)
Ann Oncol
, vol.20
, pp. 1913-1927
-
-
Gluz, O.1
Liedtke, C.2
Gottschalk, N.3
Pusztai, L.4
Nitz, U.5
Harbeck, N.6
-
5
-
-
84867118148
-
Emerging targeted therapies in triple-negative breast cancer
-
J. Crown, J. O'Shaughnessy, and G. Gullo Emerging targeted therapies in triple-negative breast cancer Ann Oncol 23 2012 vi56 vi65
-
(2012)
Ann Oncol
, vol.23
-
-
Crown, J.1
O'Shaughnessy, J.2
Gullo, G.3
-
7
-
-
0028102893
-
Quercetin-induced benzophenanthridine alkaloid production in suspension cell cultures of Sanguinaria canadensis
-
DOI 10.1055/s-2006-959570
-
G.B. Mahady, and C.W.W. Beecher Quercetin-induced benzophenanthridine alkaloid production in suspension cell cultures of Sanguinaria canadensis Planta Med 60 1994 553 557 (Pubitemid 24382567)
-
(1994)
Planta Medica
, vol.60
, Issue.6
, pp. 553-557
-
-
Mahady, G.B.1
Beecher, C.W.W.2
-
8
-
-
0029829338
-
Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism
-
DOI 10.1055/s-2006-957924
-
C. Vavrěcková, I. Gawlik, and K. Müller Benzophenanthridine alkaloids of Chelidonium majus: inhibition of 5- and 12-lipoxygenase by a non-redox mechanism Planta Med 62 1996 397 401 (Pubitemid 26370327)
-
(1996)
Planta Medica
, vol.62
, Issue.5
, pp. 397-401
-
-
Vavreckova, C.1
Gawlik, I.2
Muller, K.3
-
9
-
-
84866981349
-
Alkaloids isolated from natural herbs as the anticancer agents
-
ID 485042
-
J.J. Lu, J.L. Bao, X.P. Chen, M. Huang, and Y.T. Wang Alkaloids isolated from natural herbs as the anticancer agents Evid-Based Complement Alternat Med 2012 2012 ID 485042
-
(2012)
Evid-Based Complement Alternat Med
, vol.2012
-
-
Lu, J.J.1
Bao, J.L.2
Chen, X.P.3
Huang, M.4
Wang, Y.T.5
-
10
-
-
0024313747
-
Antimicrobial action of sanguinarine
-
K.C. Godowski Antimicrobial action of sanguinarine J Clin Dent 1 1989 96 101 (Pubitemid 19235665)
-
(1989)
Journal of Clinical Dentistry
, vol.1
, Issue.4
, pp. 96-101
-
-
Godowski, K.C.1
-
11
-
-
0030773543
-
Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation, IκBα phosphorylation, and degradation
-
DOI 10.1074/jbc.272.48.30129
-
M.M. Chaturvedi, A. Kumar, B.G. Darnay, G.B.N. Chainy, S. Agarwal, and B.B. Aggarwal Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kB activation, IkBa phosphorylation, and degradation J Biol Chem 272 1997 30129 30134 (Pubitemid 27512211)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.48
, pp. 30129-30134
-
-
Chaturvedi, M.M.1
Kumar, A.2
Darnay, B.G.3
Chainy, G.B.N.4
Agarwal, S.5
Aggarwal, B.B.6
-
13
-
-
0034005776
-
Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells
-
N. Ahmad, S. Gupta, M.M. Husain, K.M. Heiskanen, and H. Mukhtar Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells Clin Cancer Res 6 2000 1524 1528 (Pubitemid 30226242)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.4
, pp. 1524-1528
-
-
Ahmad, N.1
Gupta, S.2
Husain, M.M.3
Heiskanen, K.M.4
Mukhtar, H.5
-
14
-
-
4444220152
-
Sanguinarine causes cell cyle blockade and apoptosis of human prostate carcinoma cells via modulation of cylin kinase inhibitor-cyclin-cyclin-dependent kinase machinery
-
V.M. Adhami, M.H. Aziz, S.R. Reagan-Shaw, M. Nihal, H. Mukhtar, and N. Ahmad Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin- dependent kinase machinery Mol Cancer Ther 3 2004 933 940 (Pubitemid 39199588)
-
(2004)
Molecular Cancer Therapeutics
, vol.3
, Issue.8
, pp. 933-940
-
-
Adhami, V.M.1
Aziz, M.H.2
Reagan-Shaw, S.R.3
Nihal, M.4
Mukhtar, H.5
Ahmad, N.6
-
15
-
-
79952842078
-
Sanguinarine suppresses prostate tumor growth and inhibits survivin expression
-
M. Sun, W. Lou, J.Y. Chun, D.S. Cho, N. Nadiminty, and C.P. Evans et al. Sanguinarine suppresses prostate tumor growth and inhibits survivin expression Genes Cancer 1 2010 283 292
-
(2010)
Genes Cancer
, vol.1
, pp. 283-292
-
-
Sun, M.1
Lou, W.2
Chun, J.Y.3
Cho, D.S.4
Nadiminty, N.5
Evans, C.P.6
-
16
-
-
70349781670
-
Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma
-
I. De Stefano, G. Raspaglio, G.F. Zannoni, D. Travaglia, M.G. Prisco, and M. Mosca et al. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma Biochem Pharmacol 78 2009 1374 1381
-
(2009)
Biochem Pharmacol
, vol.78
, pp. 1374-1381
-
-
De Stefano, I.1
Raspaglio, G.2
Zannoni, G.F.3
Travaglia, D.4
Prisco, M.G.5
Mosca, M.6
-
17
-
-
45149130752
-
Sanguinarine-induced apoptosis: Generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL
-
DOI 10.1002/jcb.21672
-
S. Kim, T.J. Lee, J. Leem, K.S. Choi, J.W. Park, and T.K. Kwon Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL J Cell Biochem 104 2008 895 907 (Pubitemid 351830838)
-
(2008)
Journal of Cellular Biochemistry
, vol.104
, Issue.3
, pp. 895-907
-
-
Kim, S.1
Lee, T.-J.2
Leem, J.3
Kyeong, S.C.4
Park, J.-W.5
Taeg, K.K.6
-
18
-
-
48049115016
-
Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway
-
W.Y. Choi, G.Y. Kim, W.H. Lee, and Y.H. Choi Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway Chemotherapy 54 2008 279 287
-
(2008)
Chemotherapy
, vol.54
, pp. 279-287
-
-
Choi, W.Y.1
Kim, G.Y.2
Lee, W.H.3
Choi, Y.H.4
-
19
-
-
33645840140
-
Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine
-
J. Holy, G. Lamont, and E. Perkins Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine BMC Cell Biol 7 2006 13 24
-
(2006)
BMC Cell Biol
, vol.7
, pp. 13-24
-
-
Holy, J.1
Lamont, G.2
Perkins, E.3
-
20
-
-
82555172397
-
Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer
-
F. Pica, E. Balestrieri, A. Serafino, R. Sorrentino, R. Gaziano, and G. Moroni et al. Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer Anticancer Drugs 23 2012 32 42
-
(2012)
Anticancer Drugs
, vol.23
, pp. 32-42
-
-
Pica, F.1
Balestrieri, E.2
Serafino, A.3
Sorrentino, R.4
Gaziano, R.5
Moroni, G.6
-
21
-
-
27744484362
-
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells
-
DOI 10.1093/carcin/bgi158
-
M. Galiè, C. Sorrentino, M. Montani, L. Micossi, E. Di Carlo, and T. D'Antuono et al. Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells Carcinogenesis 26 2005 1868 1878 (Pubitemid 41631259)
-
(2005)
Carcinogenesis
, vol.26
, Issue.11
, pp. 1868-1878
-
-
Galie, M.1
Sorrentino, C.2
Montani, M.3
Micossi, L.4
Di Carlo, E.5
D'Antuono, T.6
Calderan, L.7
Marzola, P.8
Benati, D.9
Merigo, F.10
Orlando, F.11
Smorlesi, A.12
Marchini, C.13
Amici, A.14
Sbarbati, A.15
-
22
-
-
20344398180
-
Tumor vessel compression hinders perfusion of ultrasonographic contrast agents
-
DOI 10.1593/neo.04730
-
M. Galiè, M. D'Onofrio, M. Montani, A. Amici, L. Calderan, and P. Marzola et al. Tumor vessel compression hinders perfusion of ultrasonographic contrast agents Neoplasia 7 2005 528 536 (Pubitemid 40791871)
-
(2005)
Neoplasia
, vol.7
, Issue.5
, pp. 528-536
-
-
Galie, M.1
D'Onofrio, M.2
Montani, M.3
Amici, A.4
Calderan, L.5
Marzola, P.6
Benati, D.7
Merigo, F.8
Marchini, C.9
Sbarbati, A.10
-
23
-
-
42249110515
-
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice
-
DOI 10.1038/sj.onc.1210920, PII 1210920
-
M. Galiè, G. Konstantinidou, D. Peroni, I. Scambi, C. Marchini, and V. Lisi et al. Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice Oncogene 27 2008 2542 2551 (Pubitemid 351550885)
-
(2008)
Oncogene
, vol.27
, Issue.18
, pp. 2542-2551
-
-
Galie, M.1
Konstantinidou, G.2
Peroni, D.3
Scambi, I.4
Marchini, C.5
Lisi, V.6
Krampera, M.7
Magnani, P.8
Merigo, F.9
Montani, M.10
Boschi, F.11
Marzola, P.12
Orru, R.13
Farace, P.14
Sbarbati, A.15
Amici, A.16
-
24
-
-
78649789265
-
Mesenchymal/stromal gene expression signature relates to basal-like breast cancers, identifies bone metastasis and predicts resistance to therapies
-
C. Marchini, M. Montani, G. Konstantinidou, R. Orrù, S. Mannucci, and G. Ramadori et al. Mesenchymal/stromal gene expression signature relates to basal-like breast cancers, identifies bone metastasis and predicts resistance to therapies PLoS One 5 2010 e14131
-
(2010)
PLoS One
, vol.5
, pp. 14131
-
-
Marchini, C.1
Montani, M.2
Konstantinidou, G.3
Orrù, R.4
Mannucci, S.5
Ramadori, G.6
-
25
-
-
84867760529
-
P130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells
-
B. Bisaro, M. Montani, G. Konstantinidou, C. Marchini, L. Pietrella, and M. Iezzi et al. p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells Breast Cancer Res 14 2012 137 148
-
(2012)
Breast Cancer Res
, vol.14
, pp. 137-148
-
-
Bisaro, B.1
Montani, M.2
Konstantinidou, G.3
Marchini, C.4
Pietrella, L.5
Iezzi, M.6
-
26
-
-
84890033223
-
Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling
-
C. Garulli, C. Kalogris, L. Pietrella, C. Bartolacci, C. Andreani, and M. Falconi et al. Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling Cell Signal 26 2014 352 362
-
(2014)
Cell Signal
, vol.26
, pp. 352-362
-
-
Garulli, C.1
Kalogris, C.2
Pietrella, L.3
Bartolacci, C.4
Andreani, C.5
Falconi, M.6
-
27
-
-
84892887976
-
Role of cyclin B1/Cdc2 in mediating Bcl-XL phosphorylation and apoptotic cell death following nocodazole-induced mitotic arrest
-
H.J. Choi, and B.T. Zhu Role of cyclin B1/Cdc2 in mediating Bcl-XL phosphorylation and apoptotic cell death following nocodazole-induced mitotic arrest Mol Carcinog 53 2014 125 137
-
(2014)
Mol Carcinog
, vol.53
, pp. 125-137
-
-
Choi, H.J.1
Zhu, B.T.2
-
28
-
-
81855185596
-
Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion
-
M. Sun, C. Liu, N. Nadiminty, W. Lou, Y. Zhu, and J. Yang et al. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion Prostate 72 2012 82 89
-
(2012)
Prostate
, vol.72
, pp. 82-89
-
-
Sun, M.1
Liu, C.2
Nadiminty, N.3
Lou, W.4
Zhu, Y.5
Yang, J.6
-
29
-
-
0037441888
-
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
-
DOI 10.1182/blood-2002-07-2130
-
Y. Aoki, G.M. Feldman, and G. Tosato Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma Blood 101 2003 1535 1542 (Pubitemid 36182531)
-
(2003)
Blood
, vol.101
, Issue.4
, pp. 1535-1542
-
-
Aoki, Y.1
Feldman, G.M.2
Tosato, G.3
-
30
-
-
33645067376
-
Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription
-
K. Leslie, C. Lang, G. Devgan, J. Azare, M. Berishaj, and W. Gerald et al. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription Cancer Res 66 2006 2544 2552
-
(2006)
Cancer Res
, vol.66
, pp. 2544-2552
-
-
Leslie, K.1
Lang, C.2
Devgan, G.3
Azare, J.4
Berishaj, M.5
Gerald, W.6
-
31
-
-
45849113190
-
Inhibition of STAT3 expression and signaling in resveratrol- differentiated medulloblastoma cells
-
DOI 10.1593/neo.08304
-
L.J. Yu, M.L. Wu, H. Li, X.Y. Chen, Q. Wang, and Y. Sun et al. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells Neoplasia 10 2008 736 744 (Pubitemid 351883890)
-
(2008)
Neoplasia
, vol.10
, Issue.7
, pp. 736-744
-
-
Yu, L.-J.1
Wu, M.-L.2
Li, H.3
Chen, X.-Y.4
Wang, Q.5
Sun, Y.6
Kong, Q.-Y.7
Liu, J.8
-
32
-
-
0029832419
-
Active site-directed double mutants of dihydrofolate reductase
-
E.A. Ercikan-Abali, S. Mineishi, Y. Tong, S. Nakahara, M.C. Waltham, and D. Banerjee et al. Active site-directed double mutants of dihydrofolate reductase Cancer Res 56 1996 4142 4145 (Pubitemid 26305006)
-
(1996)
Cancer Research
, vol.56
, Issue.18
, pp. 4142-4145
-
-
Ercikan-Abali, E.A.1
Mineishi, S.2
Tong, Y.3
Nakahara, S.4
Waltham, M.C.5
Banerjee, D.6
Chen, W.7
Sadelain, M.8
Bertino, J.R.9
-
33
-
-
83455236666
-
Basal breast cancer: A complex and deadly molecular subtype
-
F. Bertucci, P. Finetti, and P. Birnbaum Basal breast cancer: a complex and deadly molecular subtype Curr Mol Med 12 2012 96 110
-
(2012)
Curr Mol Med
, vol.12
, pp. 96-110
-
-
Bertucci, F.1
Finetti, P.2
Birnbaum, P.3
-
34
-
-
79951712038
-
Minireview basal-like breast cancer: From molecular profiles to targeted therapies
-
D.J. Toft, and V.L. Cryns Minireview basal-like breast cancer: from molecular profiles to targeted therapies Mol Endocrinol 25 2011 199 211
-
(2011)
Mol Endocrinol
, vol.25
, pp. 199-211
-
-
Toft, D.J.1
Cryns, V.L.2
-
37
-
-
0033574614
-
Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors
-
DOI 10.1006/jmbi.1999.2640
-
N.P. Pavletich Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and CIP and INK4 inhibitors J Mol Biol 287 1999 821 828 (Pubitemid 29188868)
-
(1999)
Journal of Molecular Biology
, vol.287
, Issue.5
, pp. 821-828
-
-
Pavletich, N.P.1
-
39
-
-
0034991780
-
Update on antifolate drugs targets
-
DOI 10.2174/1389450013348669
-
P. Costi, and S. Ferrari Update on antifolate drugs targets Curr Drug Targets 2 2001 135 166 (Pubitemid 32515036)
-
(2001)
Current Drug Targets
, vol.2
, Issue.2
, pp. 135-166
-
-
Costi, M.P.1
Ferrari, S.2
-
40
-
-
30444448872
-
Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide
-
DOI 10.1016/j.bcp.2005.10.048, PII S0006295205007161
-
M. Lindgren, K. Rosenthal-Aizman, K. Saar, E. Eiríksdóttir, Y. Jiang, and M. Sassian et al. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide Biochem Pharmacol 71 2006 416 425 (Pubitemid 43077076)
-
(2006)
Biochemical Pharmacology
, vol.71
, Issue.4
, pp. 416-425
-
-
Lindgren, M.1
Rosenthal-Aizman, K.2
Saar, K.3
Eiriksdottir, E.4
Jiang, Y.5
Sassian, M.6
Ostlund, P.7
Hallbrink, M.8
Langel, U.9
-
41
-
-
77953683770
-
Targeting nanoparticles to cancer
-
M. Wang, and M. Thanou Targeting nanoparticles to cancer Pharmacol Res 62 2010 90 99
-
(2010)
Pharmacol Res
, vol.62
, pp. 90-99
-
-
Wang, M.1
Thanou, M.2
|